0001586824-25-000005.txt : 20251222 0001586824-25-000005.hdr.sgml : 20251222 20251222073837 ACCESSION NUMBER: 0001586824-25-000005 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251222 DATE AS OF CHANGE: 20251222 EFFECTIVENESS DATE: 20251222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC. CENTRAL INDEX KEY: 0001586824 ORGANIZATION NAME: EIN: 263911659 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-564282 FILM NUMBER: 251589504 BUSINESS ADDRESS: STREET 1: 108 MONROE STREET, SUITE 202 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-337-2100 MAIL ADDRESS: STREET 1: 108 MONROE STREET, SUITE 202 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: American Gene Technologies International Inc. DATE OF NAME CHANGE: 20130913 D/A 1 primary_doc.xml X0708 D/A LIVE 0001586824 AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC. 108 MONROE STREET, SUITE 202 ROCKVILLE MD MARYLAND 20850 301-337-2100 DELAWARE American Gene Technologies International Inc. Corporation true Jeffrey Adam Galvin 199 East Montgomery Ave., Suite 100 Rockville MD MARYLAND 20850 Executive Officer Director William Drew Palin 199 East Montgomery Ave., Suite 100 Rockville MD MARYLAND 20850 Executive Officer Director Barry Haden Wells 199 East Montgomery Ave., Suite 100 Rockville MD MARYLAND 20850 Director Biotechnology Decline to Disclose 06b true 0001586824-25-000004 2025-11-03 false true true SAFE (Simple Agreement for Future Equity) false 0 10000000 310000 9690000 false 4 0 0 0 false AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC. /s/ Jeffrey Galvin Jeffrey Galvin Chief Executive Officer 2025-12-22